[1]
|
高鑫. 糖尿病防治的现状与思考[J]. 泸州医学院学报, 2017, 40(1): 1-2.
|
[2]
|
刘子琪, 刘爱萍, 王培玉. 中国糖尿病患病率的流行病学调查研究状况[J]. 中华老年多器官疾病杂志, 2015(7): 547-550.
|
[3]
|
Zhang, Y., Niu, M., Li, Y., et al. (2018) Prevalence and Risk Factors of Diabetic Retinopathy in Hospital Patients. Chinese Medical Journal, 98, 440-444.
|
[4]
|
Abdelhakim, M.A.S.E., Macky, T.A., Mansour, K.A.G., et al. (2011) Bevacizumab (Avastin) as an Adjunct to Vitrectomy in the Management of Severe Proliferative Diabetic Retinopathy: A Prospective Case Series. Ophthalmic Research, 45, 23-30. https://doi.org/10.1159/000314721
|
[5]
|
Nittala, M.G., Keane, P.A., Zhang, K., et al. (2012) Risk Factors for Proliferative Di-abetic Retinopathy in a Latino American Population. Retina, 34, 1594-1599. https://doi.org/10.1097/IAE.0000000000000117
|
[6]
|
崔颖, 郭海科, 韩云飞, 等. 2型糖尿病住院患者糖尿病视网膜病变患病率及危险因素分析[J]. 眼科新进展, 2012, 32(8): 736-739.
|
[7]
|
郭伟宾, 杨江萍, 侯娇娇, 等. 糖尿病视网膜病变的危险因素分析[J]. 解放军医药杂志, 2018(6).
|
[8]
|
Czakó, C., Sándor, G., Ecsedy, M., et al. (2018) Decreased Retinal Capillary Density Is Associated with a Higher RISK of Diabetic Retinopathy in Patients with Diabetes. Retina. https://doi.org/10.1097/IAE.0000000000002232
|
[9]
|
Kaur, N. and Vanita, V. (2016) Association of Aldose Reductase Gene (AKR1B1) Polymorphism with Diabetic Retinopathy. Diabetes Research & Clinical Practice, 121, 41-48. https://doi.org/10.1016/j.diabres.2016.08.019
|
[10]
|
Katakami, N., Kaneto, H., Takahara, M., Matsuoka, T.A., Imamura, K., Ishibashi, F., Kanda, T., Kawai, K., Osonoi, T., Matsuhisa, M., Kashiwagi, A., Kawamori, R., Shimomura, I. and Yamasaki, Y. (2011) Aldose Reductase C-106T Gene Polymorphism Is Associated with Diabetic Retinopathy in Japanese Patients with Type 2 Diabetes. Diabetes Research and Clinical Practice, 92, e57-e60. https://doi.org/10.1016/j.diabres.2011.02.017
|
[11]
|
Ren, M., Zhao, L.L., Zhang, Y., Shi, Y., Mao, Y.M. and Qi, X.Y. (2014) Relationship between Polymorphisms of Aldose Reductase Gene and Type 2 Diabetic Retinopathy. Shandong Medical Journal, 54, 20-22
|
[12]
|
Berry, D.C. and Noy, N. (2017) Retinol Binding Protein 4: Role in Diabetes and Cancer. Adipocytokines, Energy Balance, and Cancer.
|
[13]
|
Kwanbunjan, K., Panprathip, P., Phosat, C., et al. (2018) Association of Retinol Binding Protein 4 and Transthyretin with Triglyceride Levels and Insulin Resistance in Rural Thais with High Type 2 Diabetes Risk. BMC Endocrine Disorders, 18, 26. https://doi.org/10.1186/s12902-018-0254-2
|
[14]
|
Li, G., Esangbedo, I.C., Xu, L., et al. (2018) Childhood Retinol-Binding Protein 4 (RBP4) Levels Predicting the 10-Year Risk of Insulin Resistance and Metabolic Syndrome: The BCAMS Study. Cardiovascular Diabetology, 17, 69.
https://doi.org/10.1186/s12933-018-0707-y
|
[15]
|
Pandey, G.K., Balasubramanyam, J., Balakumar, M., et al. (2015) Altered Circulating Levels of Retinol Binding Protein 4 and Transthyretin in Relation to Insulin Resistance, Obesity, and Glucose Intolerance in Asian Indians. Endocrine Practice, 5, 7-13.
|
[16]
|
Li, J.Y., Chen, X.X., Lu, X.H., et al. (2018) Elevated RBP4 Plasma Levels Were Associated with Diabetic Retinopathy in Type 2 Diabetes. Bioscience Reports, 38, BSR20181100. https://doi.org/10.1042/BSR20181100
|
[17]
|
Farjo, K.M., Farjo, R.A., Halsey, S., et al. (2012) Retinol-Binding Protein 4 Induces Inflammation in Human Endothelial Cells by an NADPH Oxidase- and Nuclear Factor Kappa B-Dependent and Retinol-Independent Mechanism. Molecular & Cellular Biology, 32, 5103-5115. https://doi.org/10.1128/MCB.00820-12
|
[18]
|
Kernt, M., Hadi, I., Pinter, F., et al. (2012) Assessment of Diabetic Retinopathy Using Nonmydriatic Ultra-Widefield Scanning Laser Ophthalmoscopy (OPTOMAP) Compared with ETDRS 7-Field Stereo Photography. Diabetes Care, 35, 2459. https://doi.org/10.2337/dc12-0346
|
[19]
|
Ophthalmol, A. (1987) Photocoagulation for Diabetic Macular Edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Early Treatment Diabetic Retinopathy Study Research Group. Archives of Ophthalmology, 94, 761-774.
|
[20]
|
Jeong, S.H., Han, J.I., Cho, S.W., et al. (2016) Effect of Focal Laser Photocoagulation in Eyes with Mild to Moderate Non-Proliferative Diabetic Retinopathy. International Journal of Ophthalmology, 9, 1439.
|
[21]
|
Zhao, Y. (2018) The Role of Anti-Vascular Endothelial Growth Factor (anti-VEGF) in the Management of Proliferative Diabetic Retinopathy. Drugs in Context, 7, Article ID: 212532. https://doi.org/10.7573/dic.212532
|
[22]
|
Holekamp, N.M., Bouck, N. and Volpert, O. (2002) Pigment Epithelium-Derived Factor Is Deficient in the Vitreous of Patients with Choroidal Neovascularization Due to Age-Related Macular Degeneration. American Journal of Ophthalmology, 134, 220-227. https://doi.org/10.1016/S0002-9394(02)01549-0
|
[23]
|
Boyer, D.S., Yoon, Y.H., Jr., B.R., et al. (2014) Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema. Ophthalmology, 121, 1904-1914.
https://doi.org/10.1016/j.ophtha.2014.04.024
|
[24]
|
Di, M.G., Reuter, S., Hillebrand, U., et al. (2009) The Soluble VEGF Re-ceptor sFlt1 Contributes to Endothelial Dysfunction in CKD. Journal of the American Society of Nephrology, 20, 2235-2245.
https://doi.org/10.1681/ASN.2009010061
|
[25]
|
Tu, L., Wang, J.H., Barathi, V.A., et al. (2018) AAV-Mediated Gene Delivery of the Calreticulin Anti-Angiogenic Domain Inhibits Ocular Neovascularization. Angiogenesis, 21, 1-15. https://doi.org/10.1007/s10456-017-9591-4
|
[26]
|
Brănişteanu, D.C., Bilha, A. and Moraru, A. (2016) Vitrectomy Surgery of Diabetic Retinopathy Complications. Romanian Journal of Ophthalmology, 60, 31-36.
|